Structured Summary
Abstract
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
5 entry terms
- Movement Disorder Agents
- Agents, Anti-Dyskinesia
- Agents, Movement Disorder
- Anti Dyskinesia Agents
- Disorder Agents, Movement
MeSH Record
Aspects Covered
22 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
95
MeSH Record
Previous Indexing
- Antiparkinson Agents (1976-1994)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Anti-Dyskinesia Agents. Medical Subject Headings (MeSH). 2026. Unique ID D018726. http://id.nlm.nih.gov/mesh/2026/D018726
- Anti-Dyskinesia Agents. In: Wikidata. https://www.wikidata.org/wiki/Q50430254